ICG
BNGO icon

InterOcean Capital Group’s Bionano Genomics BNGO Stock Holding History

InterOcean Capital Group’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-500
Closed -$56.7K – 494
2023
Q4 		$56.7K Buy
500
+250
+100% +$26.1K ﹤0.01% 458
2023
Q3 		$45.5K Buy
+250
New +$65.5K ﹤0.01% 439

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return
CA
Cetera Advisors Denver, Colorado $12.7B AUM 22.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

InterOcean Capital Group's BNGO Position: Q1 2024 in Review

InterOcean Capital Group sold out of Bionano Genomics (BNGO) in Q1 2024, closing a stake of 500 shares — an estimated $56.7K sold.

InterOcean Capital Group first reported a position in BNGO in Q3 2023 and held it in 2 quarters. The position peaked at $56.7K in Q4 2023. 55 funds tracked by Wall St. Rank hold BNGO as of Q1 2024.

  • InterOcean Capital Group reported no remaining Bionano Genomics position as of Q1 2024 after selling out during the quarter.
  • InterOcean Capital Group sold 500 Bionano Genomics shares in Q1 2024, an estimated $56.7K.
  • InterOcean Capital Group first reported a position in Bionano Genomics in Q3 2023 and held it in 2 quarters.
  • InterOcean Capital Group's Bionano Genomics position peaked at $56.7K in Q4 2023.
  • 55 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2024.

Based on InterOcean Capital Group's 13F filing for Q1 2024, filed 13 May 2024.